(HealthDay News) — For patients with type 2 diabetes, there is an association between glucagon-like peptide-1 receptor agonist (GLP-1 RA) use and chronic cough, according to a study published online ...

A GLP-1 receptor drug first designed for diabetes, Ozempic has surged in popularity as a top contender in the weight loss ...

Women with diabetes can achieve healthy pregnancies with meticulous preparation. Experts emphasize achieving stable blood ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of ...

Get the latest on Vera Therapeutics, Inc., FDA progress for atacicept, and IgA nephropathy drug competition. Click to what to ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

Type 2 diabetes remission is possible with pharmacologic and nonpharmacologic interventions, but more research is needed on ...

People with either type 1 or type 2 diabetes have a dramatically higher risk of sudden cardiac death, which occurs when the ...

Reflux is more common in people on GLP 1 drugs and can itself cause cough. After removing these patients, GLP 1 users had a ...

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced clinical data on adipose tissue distribution in non-diabetic patients treated with sotagliflozin will be presented at the 22nd Global Cardio ...

GLP-1s are linked to lower seizure recurrence, hospitalization, and mortality risk than other glucose-lowering drugs in ...

The FDA has now started a review of the highly anticipated drug, and AZ is using a priority review voucher to shorten the ...